Now when cancer scientists are looking for solutions in diagnosis and treatment of hypoxia, sleep apnea therapies should be the first line of consideration, as sleep apnea is not just about sleep, but stopped breathing during the sleep.
Hanover Park, IL (Vocus/PRWEB) February 27, 2011
Dr. Jin Zhou, DC at PainUSA.com celebrates seventh year of Zhou’s Hypoxicology Therapy (ZHT) clinical research, for possible solutions to more medical conditions than just sleep apnea, such as malignant hypoxic tumors. He believes that both hypoxic tumor and sleep apnea may possibly share the same causes, thus need same solutions. His research was encouraged by the latest cancer research from other scientists, “Hypoxic Tumors And Their Effect On Immune Cells And Cancer Therapy”, recently published on Methods in Molecular Biology, Vol 651, 2010;651:1-29. (http://www.ncbi.nlm.nih.gov/pubmed/20686957)
With obvious and satisfactory clinical benefits from ZHT in early clinical observations for sleep apnea and anecdotal benefits for clinical hypoxia, Dr. Zhou is seeking for alternative solutions to sleep apnea and hypoxic tumors that are completely supernatural and most economical.
Intriguingly, the latest research by the investigators from Center for Cell and Gene Therapy, Baylor College of Medicine in, Houston, TX, revealed the following important findings, published in Hypoxic Tumors And Their Effect On Immune Cells And Cancer Therapy: (http://www.ncbi.nlm.nih.gov/pubmed/20686957)
“The abnormal decrease or the lack of oxygen supply to cells and tissues is called hypoxia. This condition is commonly seen in various diseases such as rheumatoid arthritis and atherosclerosis, also in solid cancers. Pre-clinical and clinical studies have shown that hypoxic cancers are extremely aggressive, resistant to standard therapies (chemotherapy and radiotherapy), and thus very difficult to eradicate. Hypoxia affects both the tumor and the immune cells via various pathways. This review summarizes the most common effects of hypoxia on immune cells that play a key role in the anti-tumor response, the limitation of current therapies, and the potential solutions that were developed for hypoxic malignancies.”
After reviewing current research data, the investigators concluded that it is evidently clear that current standard cancer therapies are limited and inefficient for malignant tumors, as hypoxic areas of tumors are aggressive and metastatic, and often resistant to standard chemotherapy and radiotherapy. “It is crucial to rethink and improve non-surgical therapies for these malignancies”.
“It is clear and straightforward that hypoxic tumors are the result of overall body hypoxia, from No. 1 cause of hypoxia, sleep apnea. Now when cancer scientists are looking for solutions in diagnosis and treatment of hypoxia, sleep apnea therapies should be the first line of consideration, as sleep apnea is not just about sleep, but stopped breathing during the sleep, hypoxia without your knowing about it,” said Dr. Jin Zhou, the innovator of Zhou’s Hypoxicology Therapy (ZHT), who coined the word, “Hypoxicology”.
“However, it is not so easy to eliminate body hypoxia when not knowing the existent of hypoxia, even when professional and public awareness of sleep apnea is increasing evident in the past 5 years. The motivation from the industry and government to find a new holistic solution to cancer is also questionable or less evident,” added Dr. Zhou.
It is very important to find non-surgical and non-pharmaceutical long term solutions to eradicate hypoxic tumors, in conjunction with standard cancer therapies, at least to overcome current limitations of standard cancer therapies and to improve the overall efficacy of tumor treatment, explained Dr. Zhou, for his ZHT research.
In his on-going research for a natural solution to human hypoxia, Dr. Zhou noted that the most of the current therapies for sleep apnea are all extrinsic with surgery and devices, rather than intrinsic with human body functions and innate immune powers. Dr. Zhou believes that in order to eliminate sleep apnea and hypoxia, and hypoxic effects of tumor microenvironment, we must identify and eliminate the root causes of the hypoxia and cancer, thus an intrinsic approach is inevitable. That is the reason for him to develop Zhou’s Hypoxicology Therapy (ZHT).
After reviewing the recent scientific discovery, Dr. Zhou hypothesized that Hypoxia from sleep apnea or sleep disorder breathing is the macro-environment or macro-pathology, and baroreflex or chemoreflex dysfunction, and resultant hypoxic tumor effects are the microenvironment or micro-pathology.
“Never claim for cure for any modern medical diagnosis, a natural solution with mother nature human body functions will be the most powerful protections against tumors and sleep apnea,” disclaimed Dr. Zhou.
For sleep apnea research, Dr. Zhou developed a hypothesis that trachea caudal displacement (TCD) and vocal cord dysfunction (VCD) primarily impair baroreflex function of carotid sinus, and the reversal of TCD and VCD as well as volitional resuscitation with upper airway defense reflex may reverse sleep apnea thus benefit persistent hypertension management.
In developing the new ZHT (Zhou’s Hypoxicology Therapy) alternatives for sleep apnea, Dr. Zhou, observed clinically that trachea caudal displacement (TCD) (the windpipe moving downward), resulted from diaphragm malfunction and baroreflex dysfunction, instead of weakened soft appellate as claimed by the mainstream scientists, is the main anatomical pathology for snoring, collapse of the upper airway and frequent breathing stops during the night for people with obstructive sleep apnea. In addition, as Dr. Zhou hypothesized, the dysfunction of the baroreflex, chemoreflex, metabo-reflex, mechanoreflex, psychosomato-reflex and respiration pace-making malfunction, due to psychological, environmental and anatomical causations, are primarily and intricately responsible for the obstructive and central sleep apnea development.
Clinically, ZHT employs unique breathing and reflex exercises in conjunction with chiropractic manual and therapeutic exercises to reset baroreflex and functional fitness of upper airway. ZHT is simple, natural and quick for clinical results. Under ZHT Sleep Apnea Protocol, a patient is expected to see definitive noticeable results on the first visit with increasing uvulo-palatal-pharyngeal space and diaphragm breathing; significant and satisfactory results of both anatomical and functional breathing improvements, and activities of daily living (ADL) improvements within three sessions or if not so, ZHT therapy should be discontinued.
Dr. Jin Zhou, D.C. has been a licensed chiropractic physician in Hanover Park, IL since 1991. He was a former orthopedic surgeon 23 years ago in China. Dr. Zhou is dedicated to developing a revolutionary breakthrough, an extremely simple and super natural therapy that could potentially save millions of lives and trillions of dollars without having to rely upon only medication, surgery and device. He coined the new word, “Hypoxicology”.
For more scientific information on ZHT, please visit http://SleepapneaUSA.net, or contact Dr. Jin Zhou at 630-808-7237.
For more clinical information on sleep apnea, please visit http://PainUSA.com, or contact DR. Jin Zhou at 630-736-1646.